LLY

1,005.32

+0.99%↑

JNJ

244.16

+0.94%↑

ABBV

227.42

+1.18%↑

NVS

162.4

+1.23%↑

AZN

197.55

+2.64%↑

LLY

1,005.32

+0.99%↑

JNJ

244.16

+0.94%↑

ABBV

227.42

+1.18%↑

NVS

162.4

+1.23%↑

AZN

197.55

+2.64%↑

LLY

1,005.32

+0.99%↑

JNJ

244.16

+0.94%↑

ABBV

227.42

+1.18%↑

NVS

162.4

+1.23%↑

AZN

197.55

+2.64%↑

LLY

1,005.32

+0.99%↑

JNJ

244.16

+0.94%↑

ABBV

227.42

+1.18%↑

NVS

162.4

+1.23%↑

AZN

197.55

+2.64%↑

LLY

1,005.32

+0.99%↑

JNJ

244.16

+0.94%↑

ABBV

227.42

+1.18%↑

NVS

162.4

+1.23%↑

AZN

197.55

+2.64%↑

Home・Akciju saraksts・Microbot Medical Inc

Microbot Medical Inc

Atvērts

2.55 6.69

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

2.38

Max

2.61

Galvenie mērījumi
By Trading Economics
Ienākumi	-77K -3.6M
Darbinieki	20
EBITDA	-79K -3.6M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+215.13% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 23. marts

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	26M 167M
Iepriekšējā atvēršanas cena	-4.14
Iepriekšējā slēgšanas cena	2.55

Tehniskais rādītājs

By Trading Central

Pārliecība

Neutral Evidence

2.52 / 2.57 Atbalsts un pretestība

Microbot Medical Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 9. marts 18:13 UTC

Iegādes, apvienošanās, pārņemšana

Shell to Sell Jiffy Lube to Monomoy in $1.3 Billion Deal -- Update

2026. g. 9. marts 17:20 UTC

Galvenie ziņu notikumi

U.S. Ag Industry Calls for Government Intervention on Fertilizer Prices

2026. g. 9. marts 17:15 UTC

Iegādes, apvienošanās, pārņemšana

Shell to Sell Jiffy Lube and Premium Velocity to Monomoy for $1.3 Billion

2026. g. 10. marts 00:00 UTC

Galvenie ziņu notikumi

Why Iranian Regime Change Would Transform Global Energy Markets -- WSJ

2026. g. 9. marts 23:52 UTC

Tirgus saruna

Gold Steady; May Be Supported by Dollar's Weakness -- Market Talk

2026. g. 9. marts 23:50 UTC

Tirgus saruna

Nikkei May Rise as Fears About Higher Energy Prices Ease -- Market Talk

2026. g. 9. marts 23:50 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 9. marts 23:46 UTC

Tirgus saruna

Galvenie ziņu notikumi

Correction to Crude Prices Market Talk on March 9

2026. g. 9. marts 23:42 UTC

Tirgus saruna

Galvenie ziņu notikumi

Oil Futures Fall Amid Developments That Could Help Supply -- Market Talk

2026. g. 9. marts 23:08 UTC

Galvenie ziņu notikumi

Front-Month WTI Futures Drop 7.9% to $87.29/bbl, ICE Data Show

2026. g. 9. marts 23:07 UTC

Galvenie ziņu notikumi

Front-Month WTI Futures Fall After Trump Says Iran War Will Be Over 'Very Soon'

2026. g. 9. marts 21:29 UTC

Iegādes, apvienošanās, pārņemšana

Fortescue Now Fully Owns Peru's Canariaco Copper Project

2026. g. 9. marts 21:28 UTC

Iegādes, apvienošanās, pārņemšana

Fortescue Completes Acquisition of Remaining Alta Copper Shares

2026. g. 9. marts 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 9. marts 20:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 9. marts 20:47 UTC

Galvenie ziņu notikumi

The 24 Hours When Oil Markets Went Wild -- WSJ

2026. g. 9. marts 20:33 UTC

Galvenie ziņu notikumi

Stock Market Today: Oil Slips, Stocks Bounce on Trump War-Progress Comments Headline -- WSJ

2026. g. 9. marts 20:14 UTC

Tirgus saruna

Galvenie ziņu notikumi

Oil Moves Lower As Trump Says War Could End Soon -- Market Talk

2026. g. 9. marts 19:33 UTC

Galvenie ziņu notikumi

High Oil Prices Could Crimp Convenience Store Margins -- Barrons.com

2026. g. 9. marts 19:17 UTC

Tirgus saruna

Galvenie ziņu notikumi

Prospect of Added Supply From Oil Reserves Ease Inflation Fears -- Market Talk

2026. g. 9. marts 19:14 UTC

Tirgus saruna

Oil Settles Off Highs As G7 Discusses Tapping Reserves -- Market Talk

2026. g. 9. marts 19:00 UTC

Tirgus saruna

U.S. Natural Gas Futures Settle Lower -- Market Talk

2026. g. 9. marts 18:23 UTC

Tirgus saruna

Galvenie ziņu notikumi

BofA Drops Canada Rate-Cut Call on Higher Oil Prices -- Market Talk

2026. g. 9. marts 17:58 UTC

Iegādes, apvienošanās, pārņemšana

Shell to Sell Jiffy Lube to Monomoy in $1.3B Deal -- Update

2026. g. 9. marts 17:57 UTC

Iegādes, apvienošanās, pārņemšana

Activist Investors Target Food Companies as Growth Slows. Lamb Weston Is the Latest. -- Barrons.com

2026. g. 9. marts 17:41 UTC

Galvenie ziņu notikumi

U.S. and Western Allies Turn to Reserves to Counteract Gulf Oil Crisis -- WSJ

2026. g. 9. marts 17:41 UTC

Tirgus saruna

Galvenie ziņu notikumi

Reports of Saudi Production Shut-Ins Keep Bid in Crude -- Market Talk

2026. g. 9. marts 17:08 UTC

Tirgus saruna

Canada Rate Outlook Shifts From Long Pause to Late 2026 Hike -- Market Talk

2026. g. 9. marts 17:04 UTC

Tirgus saruna

Galvenie ziņu notikumi

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 9. marts 17:04 UTC

Tirgus saruna

Galvenie ziņu notikumi

Treasury Yields, Dollar Off Highs as G7 Tackles Oil Shock -- Market Talk

Salīdzinājums

Cenas izmaiņa

Microbot Medical Inc Prognoze

Cenas mērķis

By TipRanks

215.13% augšup

Prognoze 12 mēnešiem

Vidējais 7.5 USD 215.13%

Augstākais 12 USD

Zemākais 5 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Microbot Medical Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

3 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 3 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Microbot Medical Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

2.52 / 2.57Atbalsts un pretestība

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.